Cancer Letters
Volume 208, Issue 2 , Pages 171-178, 28 May 2004

VR-3848, a novel peptide derived from Euphobiaceae, induces mitochondria-dependent apoptosis in human leukemia cells

  • Wanlaya Uthaisang

      Affiliations

    • Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
    • Institute of Environmental Medicine, Division of Toxicology, Nobels väg 13, Karolinska Institutet, 171 77 Stockholm, Sweden
  • ,
  • Vichai Reutrakul

      Affiliations

    • Department of Chemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
  • ,
  • Chongkon Krachangchaeng

      Affiliations

    • Department of Chemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
  • ,
  • Prapon Wilairat

      Affiliations

    • Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
  • ,
  • Bengt Fadeel

      Affiliations

    • Institute of Environmental Medicine, Division of Toxicology, Nobels väg 13, Karolinska Institutet, 171 77 Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46-8-728-7556; fax: +46-8-32-90-41

Received 14 November 2003; received in revised form 19 December 2003; accepted 21 January 2004.

Abstract 

VR-3848, a novel peptide derived from Euphobiaceae, is shown herein to induce apoptosis at nanomolar concentrations in the leukemic Jurkat cell line. Apoptosis was associated with activation of caspases, release of cytochrome c from mitochondria, fragmentation of nuclear DNA, and externalization of phosphatidylserine on the cell surface. Overexpression of mitochondria-targeted Bcl-2 abrogated VR-3848-induced killing in this model. Primary human interleukin (IL)-2-activated T lymphocytes were considerably less sensitive to VR-3848-induced apoptosis as compared to Jurkat cells. VR-3848 thus holds the promise of being a potent and selective anti-cancer agent that deserves further exploration.

Keywords:  Apoptosis, Caspase, Euphobiaceae, Mitochondria, Peptide

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(04)00103-X

doi:10.1016/j.canlet.2004.01.024

Cancer Letters
Volume 208, Issue 2 , Pages 171-178, 28 May 2004